Correlation of Fc-γ RIIA polymorphisms with latent Epstein–Barr virus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas

References

• Moi ML, Lim CK, Takasaki T, et al. Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. J Gen Virol 2010;91:103–111.
   PubMed Web of Science ®Google Scholar
• Indik ZK, Park JG, Hunter S, et al. The molecular dissection of Fc gamma receptor mediated phagocytosis. Blood 1995;86:4389–4399.
   PubMed Web of Science ®Google Scholar
• Powell MS, Barton PA, Emmanouilidis D, et al. Biochemical analysis and crystallisation of Fc gamma RIIa, the low affinity receptor for IgG. Immunol Lett 1999;68:17–23.
   PubMed Web of Science ®Google Scholar
• de Haas M. IgG-Fc receptors and the clinical relevance of their polymorphisms. Wien Klin Wochenschr 2001;113:825–831.
   PubMed Web of Science ®Google Scholar
• Reilly AF, Norris CF, Surrey S, et al. Genetic diversity in human Fc receptor II for immunoglobulin G: Fc gamma receptor IIA ligand-binding polymorphism. Clin Diagn Lab Immunol 1994;1:640–644.
   PubMedGoogle Scholar
• van Schie RC, Wilson ME. Evaluation of human FcgammaRIIA (CD32) and FcgammaRIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA. Clin Diagn Lab Immunol 2000l;7:676–681.
   PubMedGoogle Scholar
• Karassa FB, Trikalinos TA, Ioannidis JP. The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases. Biomed Pharmacother 2004;58:286–291.
   PubMed Web of Science ®Google Scholar
• Pradhan V, Patwardhan M, Nadkarni A, et al. Fc γ RIIA genotypes and its association with anti-C1q autoantibodies in lupus nephritis (LN) patients from Western India. Autoimmune Dis 2010;2010:470695.
   PubMedGoogle Scholar
• Yesmin K, Hargreaves C, Newby PR, et al. Association of FcGRIIa with Graves’ disease: a potential role for dysregulated autoantibody clearance in disease onset/progression. Clin Endocrinol 2010;73: 119–125.
   PubMed Web of Science ®Google Scholar
• Carcao MD, Blanchette VS, Wakefield CD, et al. Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura. Br J Haematol 2003;120:135–141.
   PubMedGoogle Scholar
• Karassa FB, Bijl M, Davies KA, et al. Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis. Arthritis Rheum 2003;48:1930–1938.
   PubMed Web of Science ®Google Scholar
• Platonov AE, Shipulin GA, Vershinina IV, et al. Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin Infect Dis 1998;27: 746–750.
   PubMed Web of Science ®Google Scholar
• Bredius RG, Derkx BH, Fijen CA, et al. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994;170:848–853.
   PubMed Web of Science ®Google Scholar
• Sanders LA, van de Winkel JG, Rijkers GT, et al. Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 1994;170:854–861.
   PubMed Web of Science ®Google Scholar
• Dahmer MK, Randolph A, Vitali S, et al. Genetic polymorphisms in sepsis. Pediatr Crit Care Med 2005;6:S61–S73.
   Google Scholar
• Brouwer KC, Lal RB, Mirel LB, et al. Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection. AIDS 2004;18:1187–1194.
   PubMed Web of Science ®Google Scholar
• Forthal DN, Landucci G, Bream J, et al. FcgammaRIIa genotype predicts progression of HIV infection. J Immunol 2007;179:7916–7923.
   PubMed Web of Science ®Google Scholar
• Tarrand JJ, Keating MJ, Tsimberidou AM, et al. Epstein-Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia. Cancer 2010;116:880–887.
   PubMed Web of Science ®Google Scholar
• Tsimberidou AM, Keating MJ, Bueso-Ramos CE, et al. Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot study. Leuk Lymphoma 2006;47:827–836.
   PubMed Web of Science ®Google Scholar
• Tsimberidou AM, Keating MJ. Richter's transformation in chronic lymphocytic leukemia. Semin Oncol 2006;33:250–256.
   PubMed Web of Science ®Google Scholar
• Niedobitek G, Agathanggelou A, Herbst H, et al. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J Pathol 1997;182:151–159.
   PubMed Web of Science ®Google Scholar
• Fafi-Kremer S, Morand P, Germi R, et al. A prospective follow-up of Epstein-Barr virus LMP1 genotypes in saliva and blood during infectious mononucleosis. J Infect Dis 2005;192:2108–2111.
   PubMed Web of Science ®Google Scholar
• Tierney RJ, Steven N, Young LS, et al. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 1994;68: 7374–7385.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008.
   Google Scholar
• Kubota N, Wada K, Ito Y, et al. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection. J Virol Methods 2008;147:26–36.
   PubMed Web of Science ®Google Scholar
• Weikert S, Christoph F, Schrader M. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Int J Cancer 2005;116:100–104.
   PubMed Web of Science ®Google Scholar
• Drakos E, Thomaides A, Medeiros LJ, et al. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma. Clin Cancer Res 2007;13:3380–3387.
   PubMed Web of Science ®Google Scholar
• Jiang XM, Arepally G, Poncz M, et al. Rapid detection of the Fc gamma RIIA-H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED). J Immunol Methods 1996;199:55–59.
   PubMed Web of Science ®Google Scholar